Cyclosporin A in the treatment of adult onset Still’s disease
More details
Hide details
Online publication date: 2006-12-15
Reumatologia 2006;44(6):381-383
Still’s disease is a subset of arthritis which usually appears before the age of 16 (juvenile onset Still’s disease). In subjects who are over 16 it is classified as adult onset Still’s disease. This report describes a 43-year-old male patient diagnosed with Still’s disease according to Yamaguchi criteria (May 2003). The treatment with glycocorticosteroids in monotherapy and also combined with azathioprine was unsuccessful. The remission that lasts until now was achieved after cyclosporine A (CsA) was introduced. According to the literature methotrexate (Mtx) is recommended as the first choice medication. CsA seems to be a reasonable alternative to methotrexate in Still’s disease.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Journals System - logo
Scroll to top